Literature DB >> 11818089

Antepartum prophylactic transabdominal amnioinfusion in preterm pregnancies complicated by oligohydramnios.

N O Turhan1, N Atacan.   

Abstract

OBJECTIVE: To assess the role of amnioinfusion in preterm pregnancies with oligohydramnios.
METHOD: 29 women between 23 and 35 weeks' gestation were enrolled in the study. Transabdominal amnioinfusion was performed in 15 pregnancies, 14 patients were managed expectantly. The latency period and perinatal outcome of both groups were compared using the Mann-Whitney U-test and chi(2)-test. RESULT: The amniotic fluid index significantly increased from a median value of 6 to 11 cm (P<0.0001) in the amnioinfusion group after amnioinfusion. The latency period of the amnioinfusion group was significantly longer (median 15 vs. 8 days P<0.05). Gestational week of the amnioinfusion group was earlier on admission (median 30.6 vs. 33.4 weeks, P=0.01) but at delivery this diversity disappeared (median 33.4 vs. 34.8 weeks, P=0.10). The perinatal outcomes of the two groups were similar.
CONCLUSION: Transabdominal amnioinfusion prolongs the latency period and improves perinatal outcome in preterm pregnancies complicated by oligohydramnios.

Entities:  

Mesh:

Year:  2002        PMID: 11818089     DOI: 10.1016/s0020-7292(01)00504-5

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  2 in total

1.  The Effects of Intravenous Hydration on Amniotic Fluid Index in Pregnant Women with Preterm premature Rupture of Membranes: A Randomized Clinical Trial.

Authors:  Mahnaz Shahnazi; Simin Tagavi; Khadije Hajizadeh; Azize Farshbaf Khalili
Journal:  J Caring Sci       Date:  2013-02-26

2.  Oligohydramnios: a prospective study of fetal, neonatal and maternal outcomes in low-middle income countries.

Authors:  Lester Figueroa; Elizabeth M McClure; Jonathan Swanson; Robert Nathan; Ana L Garces; Janet L Moore; Nancy F Krebs; K Michael Hambidge; Melissa Bauserman; Adrien Lokangaka; Antoinette Tshefu; Waseem Mirza; Sarah Saleem; Farnaz Naqvi; Waldemar A Carlo; Elwyn Chomba; Edward A Liechty; Fabian Esamai; David Swanson; Carl L Bose; Robert L Goldenberg
Journal:  Reprod Health       Date:  2020-01-30       Impact factor: 3.223

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.